1997
DOI: 10.7164/antibiotics.50.484
|View full text |Cite
|
Sign up to set email alerts
|

Inhibitors of Type-I Interleukin-1 Receptor from Microbial Metabolites.

Abstract: Wedescribe here the results of a screening program conducted to discover inhibitors of the type-I interleukin-1 receptor (IL-1RI) from samples of microbial origin. An innovative approach, based on automated, nonradioactive receptor binding assays has been employed. Specially prepared cell-free systems have allowed the use of high concentrations ofmicrobial metabolites in the reaction mixtures with a low percentage of false positives. More than 30,000 microbial samples from different species of soil isolates ha… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
5
0

Year Published

1999
1999
2024
2024

Publication Types

Select...
7
1

Relationship

0
8

Authors

Journals

citations
Cited by 9 publications
(5 citation statements)
references
References 10 publications
0
5
0
Order By: Relevance
“…Biochemically, avipin inhibits electron transport, oxidative phosphorylation and protein synthesis, possibly as a result of the aromatic orthodialdehyde functionality cross-linking lysine residues in the proteins of cytochrome C and mitochondrial membranes (White & Elliott, 1972Madrigal & Melgarejo, 1994). Other biochemical effects include inhibition of interleukin-1 receptors and glucose-6-phosphat e translocase (Stefanelli et al, 1997;Vertesy et al, 1999).…”
Section: Discussionmentioning
confidence: 95%
“…Biochemically, avipin inhibits electron transport, oxidative phosphorylation and protein synthesis, possibly as a result of the aromatic orthodialdehyde functionality cross-linking lysine residues in the proteins of cytochrome C and mitochondrial membranes (White & Elliott, 1972Madrigal & Melgarejo, 1994). Other biochemical effects include inhibition of interleukin-1 receptors and glucose-6-phosphat e translocase (Stefanelli et al, 1997;Vertesy et al, 1999).…”
Section: Discussionmentioning
confidence: 95%
“…Azalomycin F has remarkable bioactivities against Gram-positive bacteria, yeast, fungi, and protozoa [17,34,73,75], and some clinical studies on its anti-trichomoniasis and anti-candida infectious effects were performed [34], while no corresponding drug was approved in the clinic. Stefanelli et al discovered that niphimycin ( 28 ) and azalomycin F ( 8 – 10 ) could inhibit the type-I interleukin-1 receptor [55]. Moreover, they had remarkable activities against phytopathogenic fungi, such as Fusarium oxysporum , Fusarium moliniforme , Asparagus officinalis , Rhizoctonia solani, Colletotrichum gloeosporioides , and Alternaria mali [17,36].…”
Section: Bioactivitymentioning
confidence: 99%
“…There are about thirty 36-membered polyhydroxyl macrolides identified so far, and almost all of them were produced by Streptomyces . These compounds possess broad-spectrum antimicrobial activity, and azalomycin F was also an inhibitor of type-I interleukin-1 receptor [27]. In our research on biological activity of azalomycin F analogs produced by Streptomyces sp.…”
Section: Resultsmentioning
confidence: 99%